Author

K. Stephens

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:rat· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. Creanga· 1 shared A. Derrien-Colemyn· 1 shared A. Pegu· 1 shared A. R. Henry· 1 shared B. A. Pinsky· 1 shared B. S. Graham· 1 shared C. B. Greenacre· 1 shared C. Billings· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Creanga

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Replacement of tibialis cranialis tendon with polyester, silicone-coated artificial tendon preserves biomechanical function in rabbits

K. L. Easton, C. Hatch, K. Stephens, D. Marler, O. P. Fidelis, X. Sun, K. M. Bowers, C. Billings, C. B. Greenacre, D. E. Anderson, D. L. Crouch

This study evaluates an artificial tendon in rabbits, finding it preserves biomechanical function compared to tendon excision.

bioRxiv · Oct 25, 2023 · PreprintBioengineering

Placental nanoparticle gene therapy normalizes gene expression changes in the fetal liver associated with fetal growth restriction in a fetal sex-specific manner

R. Wilson, K. Stephens, H. Jones

This study shows that placental nanoparticle gene therapy with hIGF-1 reduces sex-specific gene expression changes in fetal livers of growth-restricted fetuses.

bioRxiv · Sep 26, 2022Physiology

Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant

V.-V. Edara, L. Lai, M. Sahoo, K. Floyd, M. Sibai, D. Solis, M. W. Flowers, L. Hussaini, C. R. Ciric, S. Bechnack, K. Stephens, E. B. Mokhtari, P. Mudvari, A. Creanga, A. Pegu, , M. Suthar

This study assesses neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant in convalescent and vaccinated individuals, finding it is 6.8-fold more resistant but still neutralizable.

bioRxiv · May 9, 2021 · PreprintImmunology